BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28992939)

  • 1. Kidney function, bone-mineral metabolism markers, and future risk of peripheral artery disease.
    Yang C; Kwak L; Ballew SH; Garimella PS; Jaar BG; Folsom AR; Heiss G; Selvin E; Lutsey PL; Coresh J; Matsushita K
    Atherosclerosis; 2017 Dec; 267():167-174. PubMed ID: 28992939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum magnesium, bone-mineral metabolism markers and their interactions with kidney function on subsequent risk of peripheral artery disease: the Atherosclerosis Risk in Communities Study.
    Menez S; Ding N; Grams ME; Lutsey PL; Heiss G; Folsom AR; Selvin E; Coresh J; Jaar BG; Matsushita K
    Nephrol Dial Transplant; 2020 Nov; 35(11):1878-1885. PubMed ID: 32191294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers of Mineral and Bone Metabolism and 20-Year Risk of Hospitalization With Infection: The Atherosclerosis Risk in Communities Study.
    Ishigami J; Jaar BG; Rebholz CM; Grams ME; Michos ED; Wolf M; Kovesdy CP; Uchida S; Coresh J; Lutsey PL; Matsushita K
    J Clin Endocrinol Metab; 2017 Dec; 102(12):4648-4657. PubMed ID: 29029099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population.
    Astor BC; Shafi T; Hoogeveen RC; Matsushita K; Ballantyne CM; Inker LA; Coresh J
    Am J Kidney Dis; 2012 May; 59(5):653-62. PubMed ID: 22305758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in novel filtration markers and risk of ESRD.
    Rebholz CM; Grams ME; Matsushita K; Selvin E; Coresh J
    Am J Kidney Dis; 2015 Jul; 66(1):47-54. PubMed ID: 25542414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of kidney function and albuminuria with prevalent and incident hypertension: the Atherosclerosis Risk in Communities (ARIC) study.
    Huang M; Matsushita K; Sang Y; Ballew SH; Astor BC; Coresh J
    Am J Kidney Dis; 2015 Jan; 65(1):58-66. PubMed ID: 25151408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney function, bone-mineral metabolism markers, and calcification of coronary arteries, aorta, and cardiac valves in older adults.
    Mok Y; Wang F; Ballew SH; Menez S; Butler KR; Wagenknecht L; Sedaghat S; Lutsey PL; Coresh J; Blaha MJ; Matsushita K
    Atherosclerosis; 2023 Mar; 368():35-43. PubMed ID: 36754659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in Multiple Filtration Markers and Subsequent Risk of Cardiovascular Disease and Mortality.
    Rebholz CM; Grams ME; Matsushita K; Inker LA; Foster MC; Levey AS; Selvin E; Coresh J
    Clin J Am Soc Nephrol; 2015 Jun; 10(6):941-8. PubMed ID: 25825481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β2-microglobulin, cystatin C, and creatinine and risk of symptomatic peripheral artery disease.
    Joosten MM; Pai JK; Bertoia ML; Gansevoort RT; Bakker SJ; Cooke JP; Rimm EB; Mukamal KJ
    J Am Heart Assoc; 2014 Jun; 3(4):. PubMed ID: 24980133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney function and sudden cardiac death in the community: The Atherosclerosis Risk in Communities (ARIC) Study.
    Suzuki T; Agarwal SK; Deo R; Sotoodehnia N; Grams ME; Selvin E; Calkins H; Rosamond W; Tomaselli G; Coresh J; Matsushita K
    Am Heart J; 2016 Oct; 180():46-53. PubMed ID: 27659882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney function estimated from serum creatinine and cystatin C and peripheral arterial disease in NHANES 1999-2002.
    Selvin E; Köttgen A; Coresh J
    Eur Heart J; 2009 Aug; 30(15):1918-25. PubMed ID: 19487236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GFR Estimation Using β-Trace Protein and β2-Microglobulin in CKD.
    Inker LA; Tighiouart H; Coresh J; Foster MC; Anderson AH; Beck GJ; Contreras G; Greene T; Karger AB; Kusek JW; Lash J; Lewis J; Schelling JR; Navaneethan SD; Sondheimer J; Shafi T; Levey AS
    Am J Kidney Dis; 2016 Jan; 67(1):40-8. PubMed ID: 26362696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in the Elderly: AGES-Kidney and MESA-Kidney.
    Foster MC; Levey AS; Inker LA; Shafi T; Fan L; Gudnason V; Katz R; Mitchell GF; Okparavero A; Palsson R; Post WS; Shlipak MG
    Am J Kidney Dis; 2017 Sep; 70(3):406-414. PubMed ID: 28549536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney Function and Fracture Risk: The Atherosclerosis Risk in Communities (ARIC) Study.
    Daya N; Voskertchian A; Schneider ALC; Ballew S; McAdams DeMarco M; Coresh J; Appel LJ; Selvin E; Grams ME
    Am J Kidney Dis; 2016 Feb; 67(2):218-226. PubMed ID: 26250781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor-23 and the long-term risk of hospital-associated AKI among community-dwelling older individuals.
    Brown JR; Katz R; Ix JH; de Boer IH; Siscovick DS; Grams ME; Shlipak M; Sarnak MJ
    Clin J Am Soc Nephrol; 2014 Feb; 9(2):239-46. PubMed ID: 24262510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in CKD.
    Liu X; Foster MC; Tighiouart H; Anderson AH; Beck GJ; Contreras G; Coresh J; Eckfeldt JH; Feldman HI; Greene T; Hamm LL; He J; Horwitz E; Lewis J; Ricardo AC; Shou H; Townsend RR; Weir MR; Inker LA; Levey AS;
    Am J Kidney Dis; 2016 Dec; 68(6):892-900. PubMed ID: 27663042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystatin C-based eGFR is a superior prognostic parameter to creatinine-based eGFR in post-endovascular therapy peripheral artery disease patients.
    Otaki Y; Takahashi H; Watanabe T; Yamaura G; Funayama A; Arimoto T; Shishido T; Miyamoto T; Kubota I
    Circ J; 2015; 79(11):2480-6. PubMed ID: 26354502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albuminuria and Estimated GFR as Risk Factors for Dementia in Midlife and Older Age: Findings From the ARIC Study.
    Scheppach JB; Coresh J; Wu A; Gottesman RF; Mosley TH; Knopman DS; Grams ME; Sharrett AR; Koton S
    Am J Kidney Dis; 2020 Dec; 76(6):775-783. PubMed ID: 32428540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast Growth Factor 23: A Biomarker of Kidney Function Decline.
    Drew DA; Katz R; Kritchevsky S; Ix JH; Shlipak MG; Newman AB; Hoofnagle A; Fried L; Sarnak MJ; Gutierrez OM
    Am J Nephrol; 2018; 47(4):242-250. PubMed ID: 29621752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimated GFR and risk of hip fracture in older men: comparison of associations using cystatin C and creatinine.
    Ensrud KE; Parimi N; Fink HA; Ishani A; Taylor BC; Steffes M; Cauley JA; Lewis CE; Orwoll ES;
    Am J Kidney Dis; 2014 Jan; 63(1):31-9. PubMed ID: 23890927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.